|
Year to Dec 2024
12 months to Dec 31, 2024
|
|
|---|---|
| Operating Activities | |
| Net loss for the period | |
| Item not affecting cash | |
| Amortization and depreciation | |
| Bad debts | |
| Amortization of loan initiation fees | |
| Deferred income tax expense | |
| Finance expenses | |
| Stock-based compensation | |
| Stock issued for services | |
| Lease obligation | |
| Changes in non-cash working capital | |
| Accounts receivable | |
| Other current assets | |
| Accounts payable and accrued liabilities | |
| Deferred revenue | |
| Change in long-term due from affiliate | |
| Cash Provided by (Used in) Operating Activities | |
| Investing Activities | |
| Purchase of equipment | |
| Note receivable - principal | |
| Ecker and ZooOffice acquisitions | |
| Note receivable - sale of ZenaPay | |
| Long-term investments | |
| Product development costs | |
| Cash Provided by (Used in) Investing Activities | |
| Financing activities | |
| Borrowings under line of credit | |
| Proceeds from the issuance of long-term debt | |
| Stock issuances | |
| Repayment of long-term debt | |
| Cash Provided by (Used in) Financing Activities | |
| Effect of foreign exchange on cash | |
| Change in cash | |
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance | |
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance | |
| Cash and Cash Equivalents Consist of | |
| Cash held in banks |
Loading...